168 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
SCIENTIFIC PROGRAMME
160
003
How to combine tDCS: medication or psycho-
therapy
Malek Bajbouj, Germany
004
Clinical trials in tDCS: the international
perspective
Andre Brunoni, Brazil
S-203
Symposium
17:00– 18:30
|
Hall Paris 2
TOPIC 9:
Comorbidity of somatic and mental disorders,
psychosomatics
HIV psychiatry in the 21st century – a commitment
to prevention and competent care
›
WPA Section: HIV /AIDS Psychiatry
Chairs:
César A. Alfonso, USA
Mary Ann Adler Cohen, USA
001
A model of mental health care system for
HIV-infected patients in Western Europe: the
Spanish experience
Jordi Blanch, Spain
002
Pre-exposure and post-exposure prophylaxis for
the prevention of HIV infection
Luis Pereira, USA
003
HIV and suicide – an update for the general
psychiatrist
César A. Alfonso, USA
004
The psychiatrist's role in prevention of HIV
stigma and HIV transmission
Mary Ann Adler Cohen, USA
S-204
Symposium
17:00– 18:30
|
Hall Berlin 1
TOPIC 16:
Diagnostics and classification,
psychopathology, RDoC
Embodiment, enactivism and psychiatry
›
DGPPN Section: Philosophical Foundations of Psychiatry
and Psychotherapy
Chairs:
Martin Heinze, Germany
Thomas Fuchs, Germany
001
Embodiment and intersubjectivity – an ecological
concept for psychiatry
Thomas Fuchs, Germany
002
Embodiment and social relationships – concepts
of a social world
Martin Heinze, Germany
003
Reconsidering the “basic-self” paradigm: a
clinical enquire of primary and secondary factors
Luis Madeira, Portugal
004
Phenomenological aspects of embodiment in
schizophrenia
Aaron Mishara, USA
S-205
Symposium
17:00– 18:30
|
Hall London 3
TOPIC 1:
Neurocognitive disorders, organic mental
disorders, dementia
Approaches and effects of early diagnosis of Alzhei-
mer's disease in routine and primary care
Chairs:
Frank Jessen, Germany
Jens Bohlken, Germany
001
Rational approaches to early identification
of Alzheimer's disease in the German health care
system
Michael Rapp, Germany
002
Early stage dementia care in Germany – status
quo and perspectives
Steffi G. Riedel-Heller, Germany
003
Screening for dementia in individuals without
complaints: pro and con
Frank Jessen, Germany
004
Effects of primary care based dementia screening
– 12 months follow-up
René Thyrian, Germany
S-206
Symposium
17:00– 18:30
|
Hall New York 2
TOPIC 35:
Psychiatry and society
Mental health trialogue – international research
evidence and perspective
Chairs:
Michaela Amering, Austria
Liam MacGabhann, Ireland
001
Liberating mental health communities – the
implementation of trialogue groups in Ireland
Liam MacGabhann, Ireland
002
Trialogue and psychosis seminars: research and
policy in Germany
Thomas Bock, Germany
003
Users, carers, and MH professionals on equal
footing: what does it mean to whom?
Michaela Amering, Austria
004
Users, carers and MH professionals on equal
footing: a model for LMIC?
Bhargavi Davar, India